Sort by 
Gráinne Doyne of Thérapie Fertility to receive Outstanding Contribution to the Healthcare Industry Award at the Private Healthcare Awards 2026
Gráinne Doyne, Chief Operating Officer of Thérapie Fertility, will receive the Outstanding Contribution to the Healthcare Industry Award at the Private Healthcare Awards 2026, recognised for almost 25 years of healthcare leadership spanning fertility care, pharmaceuticals, and ophthalmology, and a career defined by building accessible, evidence-based fertility services and the exceptional teams that deliver them. Her recognition reflects the depth of individual impact that sustained, purpose-driven leadership can have on Ireland's private healthcare sector, underscoring the standard of operational excellence, patient-centred commitment, and cross-sector experience that the Private Healthcare Awards celebrate.
DTZ Investors buys two Ramsay hospitals for £59.1 million
DTZ Investors has completed a £59.1 million off-market acquisition of two Ramsay Health Care hospitals in Salford and Truro from LondonMetric. The deal adds fully leased, single-tenant healthcare assets underwritten to 2037 to its investment portfolio.
Pulsenmore secures UK approval for home fertility scanner
Pulsenmore has completed MHRA registration for Pulsenmore FC, a patient-operated home ultrasound system for IVF monitoring, clearing the device for sale in the UK. The move follows the system's European regulatory approval and expands Pulsenmore beyond pregnancy monitoring into fertility care.
HCA UK installs £15m MR-guided radiotherapy system
HCA Healthcare UK has invested £15 million in an Elekta Unity MR-Linac at The Harley Street Clinic, its first installation of the system globally. The technology allows clinicians to visualise and adapt tumour treatment in real time during radiotherapy.
patientMpower trial shows 92 percent health service costs reduction
An independent randomised controlled trial has found patientMpower's remote monitoring platform cut health service costs by 92 percent and outpatient appointments by 80 percent. The results, from Manchester University NHS Foundation Trust, have already prompted expanded NHS adoption of the technology.
Duality Healthcare doubles Belfast headquarters as staff pass 100
Private healthcare provider Duality Healthcare has opened a larger Belfast headquarters as its staff numbers pass 100. The move follows a rapid expansion from a single Newry clinic in 2017 to a five-site network across Northern Ireland.
Ireland’s Public Surgical Hub Programme Clarifies the Private Market and Creates a Structural Day-Case Opportunity for Private Hospitals
Ireland’s public surgical hub network, with six hubs opening across 2026 and all explicitly restricted to public patients only, confirms that the insured day-case surgery market belongs exclusively to the private sector. Private hospitals that invest in day-case capacity, consultant breadth, and digital access now will define this market for the decade ahead.
Private Healthcare Awards 2026 set to celebrate sector's finest at Crowne Plaza Santry
Here's everything you need to know ahead of the Private Healthcare Awards 2026 ceremony, taking place on Friday, 2 October at the Crowne Plaza Hotel, Santry. From the evening's itinerary and dress code to booking deadlines and hotel rates, discover the key details guests need before the big night.
Rising Premiums and Record Coverage Levels Signal an Irish Private Health Insurance Market That Private Hospitals Must Engage With Strategically
The Health Insurance Authority’s Q1 2026 market statistics confirm the weighted average adult premium has risen to €1,960, with 2.55 million people now insured at 46% population coverage. For private hospitals, this is the moment to engage proactively with insurers on preferred provider agreements that align clinical quality with competitive value.
Nuffield Health launches UK prostate cancer blood test study
Nuffield Health has partnered with Prostate Cancer Research to run the UK's first real-world study of the Stockholm3 blood test. The Beyond-PSA study will assess whether the test can improve early detection of clinically significant prostate cancer.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
